13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001913464
Total reported value
$118.0M
$118.0M
217 檔
17.4%
At the close of Q2 2024, AlphaCentric Advisors LLC disclosed equity holdings valued at approximately $118.0M, spread across 217 reported holdings.
During Q2 2024, AlphaCentric Advisors LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
Showing top 200 holdings (of 217 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UTHR | United Therapeutics CORP | Stock-Healthcare | 3.40% | — | -9.38% | |
| 2 | BCRX | Biocryst Pharmaceuticals Inc | Stock-Other | 3.07% | — | — | |
| 3 | RITM | Rithm Capital CORP | Stock-Real Estate | 3.06% | — | -9.50% | |
| 4 | PFE | Pfizer Inc | Stock-Healthcare | 2.88% | — | -20.00% | |
| 5 | HRMY | Harmony Biosciences Holdings | Stock-Other | 2.71% | — | — | |
| 6 | PCRX | Pacira Biosciences Inc | Stock-Other | 2.48% | — | — | |
| 7 | ARGX | Argenx Se - Adr | Stock-Healthcare | 2.30% | +0.11% | -9.38% | |
| 8 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 1.98% | — | +3.33% | |
| 9 | MTG | Mgic Investment CORP | Stock-Financials | 1.82% | — | — | |
| 10 | EFC | Ellington Financial Inc | Stock-Other | 1.79% | — | -9.03% | |
| 11 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 1.61% | — | -31.91% | |
| 12 | DX | Dynex Capital Inc | Stock-Other | 1.60% | — | — | |
| 13 | ONC | Beone Medicines Ltd-adr | Stock-Other | 1.58% | — | -10.45% | |
| 14 | QURE | uniQure N.V. | Stock-Other | 1.52% | — | — | |
| 15 | AM6 | Amicus Therapeutics Inc | Stock-Other | 1.48% | — | +15.71% | |
| 16 | DCGO | Docgo Inc | Stock-Other | 1.48% | — | — | |
| 17 | RWT | Redwood Trust Inc | Stock-Other | 1.38% | — | — | |
| 18 | MFA | Mfa Financial Inc | Stock-Other | 1.31% | — | — | |
| 19 | CLDX | Celldex Therapeutics Inc | Stock-Other | 1.29% | — | +23.38% | |
| 20 | CERE1EUR | Cerevel Therapeutics Holding | Stock-Other | 1.28% | — | — | |
| 21 | CHRS | Coherus Oncology Inc | Stock-Other | 1.27% | — | — | |
| 22 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 1.20% | — | +122.22% | |
| 23 | AVBP | Arrivent Biopharma Inc | Stock-Other | 1.17% | — | +3.61% | |
| 24 | RPRX | Royalty Pharma plc | Stock-Healthcare | 1.17% | — | — | |
| 25 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 1.15% | +1.16% | NEW | |
| 26 | QQQM | Invesco Nasdaq 100 ETF | ETF-Tech | 1.15% | +1.16% | NEW | |
| 27 | DVAX | Dynavax Technologies CORP | Stock-Other | 1.08% | — | +6.12% | |
| 28 | MITT | Tpg Mortgage Investment Trus | Stock-Other | 1.02% | — | — | |
| 29 | MDT | Medtronic plc | Stock-Healthcare | 1.01% | — | -14.63% | |
| 30 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 1.01% | — | — | |
| 31 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 1.00% | — | +6.45% | |
| 32 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 0.99% | — | — | |
| 33 | ELS | Equity Lifestyle Properties | Stock-Real Estate | 0.99% | — | — | |
| 34 | ACT | Enact Holdings Inc | Stock-Other | 0.96% | — | — | |
| 35 | EXK | Exact Sciences CORP | Stock-Materials | 0.93% | — | +3.45% | |
| 36 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.89% | — | — | |
| 37 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 0.89% | +0.26% | -53.85% | |
| 38 | SNPS | Synopsys Inc | Stock-Tech | 0.88% | +0.31% | -20.00% | |
| 39 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.87% | — | +2688.10% | |
| 40 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 0.86% | +0.07% | +29.41% | |
| 41 | ADAM | Adamas Trust Inc | Stock-Other | 0.86% | — | — | |
| 42 | TWO 6.25 01-15-26Bond | Two Harbors Inv CORP | Bond | 0.85% | — | -62.40% | |
| 43 | STXS | Stereotaxis Inc | Stock-Other | 0.80% | -0.23% | — | |
| 44 | GPCR | Structure Therapeutics Inc | Stock-Other | 0.75% | — | -5.45% | |
| 45 | AMPH | Amphastar Pharmaceuticals In | Stock-Other | 0.74% | — | — | |
| 46 | KPTIEUR | Karyopharm Therapeutics Inc | Stock-Other | 0.72% | — | — | |
| 47 | RWT 5.75 10-01-25Bond | Rwt Holdings Inc | Bond | 0.72% | — | — | |
| 48 | TRML | Tourmaline Bio Inc | Stock-Other | 0.71% | — | +22.75% | |
| 49 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 0.71% | +0.13% | — | |
| 50 | IMVT | Immunovant Inc | Stock-Other | 0.71% | — | -3.95% |
According to official SEC Form 13F filings, AlphaCentric Advisors LLC reported a total U.S. public equity portfolio value of $118.0M across 217 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including UTHR, BCRX, RITM) accounted for 17.4% of total reported equity market value during Q2 2024.
During Q2 2024, AlphaCentric Advisors LLC's top holdings by market value included UTHR (3.4%)、BCRX (3.1%)、RITM (3.1%). The largest single position, UTHR, represented 3.4% of total portfolio value.
In Q2 2024, AlphaCentric Advisors LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.